AU8193191A – Method of using cold-adapted live influenza virus vaccine as an antiviral agent against influenza
– Google Patents
AU8193191A – Method of using cold-adapted live influenza virus vaccine as an antiviral agent against influenza
– Google Patents
Method of using cold-adapted live influenza virus vaccine as an antiviral agent against influenza
Info
Publication number
AU8193191A
AU8193191A
AU81931/91A
AU8193191A
AU8193191A
AU 8193191 A
AU8193191 A
AU 8193191A
AU 81931/91 A
AU81931/91 A
AU 81931/91A
AU 8193191 A
AU8193191 A
AU 8193191A
AU 8193191 A
AU8193191 A
AU 8193191A
Authority
AU
Australia
Prior art keywords
cold
antiviral agent
virus vaccine
agent against
influenza
Prior art date
1990-06-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU81931/91A
Inventor
Patricia Whitaker Dowling
Julius S Youngner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pittsburgh
Original Assignee
University of Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1990-06-27
Filing date
1991-06-24
Publication date
1992-01-23
1991-06-24
Application filed by University of Pittsburgh
filed
Critical
University of Pittsburgh
1992-01-23
Publication of AU8193191A
publication
Critical
patent/AU8193191A/en
Status
Abandoned
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K39/00—Medicinal preparations containing antigens or antibodies
A61K39/12—Viral antigens
A61K39/145—Orthomyxoviridae, e.g. influenza virus
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K39/00—Medicinal preparations containing antigens or antibodies
A61K39/12—Viral antigens
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K39/00—Medicinal preparations containing antigens or antibodies
A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
A61K2039/525—Virus
A61K2039/5254—Virus avirulent or attenuated
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
C12N2760/00011—Details
C12N2760/16011—Orthomyxoviridae
C12N2760/16111—Influenzavirus A, i.e. influenza A virus
C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y10S424/00—Drug, bio-affecting and body treating compositions
Y10S424/821—Drug, bio-affecting and body treating compositions involving temperature-sensitive mutant virus
AU81931/91A
1990-06-27
1991-06-24
Method of using cold-adapted live influenza virus vaccine as an antiviral agent against influenza
Abandoned
AU8193191A
(en)
Applications Claiming Priority (2)
Application Number
Priority Date
Filing Date
Title
US07/544,823
US5149531A
(en)
1990-06-27
1990-06-27
Method of using cold-adapted live influenza virus vaccine as an antiviral agent against influenza
US544823
1990-06-27
Publications (1)
Publication Number
Publication Date
AU8193191A
true
AU8193191A
(en)
1992-01-23
Family
ID=24173742
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU81931/91A
Abandoned
AU8193191A
(en)
1990-06-27
1991-06-24
Method of using cold-adapted live influenza virus vaccine as an antiviral agent against influenza
Country Status (3)
Country
Link
US
(1)
US5149531A
(en)
AU
(1)
AU8193191A
(en)
WO
(1)
WO1992000097A1
(en)
Families Citing this family (15)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US5840565A
(en)
*
1995-08-22
1998-11-24
The Regents Of The University Of California
Methods for enhancing the production of viral vaccines in PKR-deficient cell culture
US6855519B2
(en)
1995-08-22
2005-02-15
The Regents Of The University Of California
Methods for enhancing the production of interferon in cell culture
US6807965B1
(en)
1998-06-03
2004-10-26
Scott Laboratories, Inc.
Apparatus and method for providing a conscious patient relief from pain and anxiety associated with medical or surgical procedures
US6482414B1
(en)
1998-08-13
2002-11-19
The University Of Pittsburgh-Of The Commonwealth System Of Higher Education
Cold-adapted equine influenza viruses
US6579528B1
(en)
1998-08-13
2003-06-17
The University Of Pittsburgh – Of The Commonwealth System Of Higher Education
Cold-adapted equine influenza viruses
US6177082B1
(en)
1998-08-13
2001-01-23
The University Of Pittsburgh-Of The Commonwealth System Of Higher Education
Cold-adapted equine influenza viruses
JP2002540171A
(en)
*
1999-03-26
2002-11-26
ウォルター リード アーミー インスティテュート オブ リサーチ
Attenuated dengue type 4 virus vaccine
GB9923176D0
(en)
*
1999-09-30
1999-12-01
Smithkline Beecham Biolog
Novel composition
US7029903B2
(en)
*
2000-04-03
2006-04-18
The University Of Pittsburgh-Of The Commonwealth System Of Higher Education
Cold-adapted equine influenza viruses
TW200722101A
(en)
*
2005-03-23
2007-06-16
Glaxosmithkline Biolog Sa
Novel composition
JP5639760B2
(en)
2006-07-17
2014-12-10
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム
Influenza vaccine
US20080014217A1
(en)
*
2006-07-17
2008-01-17
Emmanuel Jules Hanon
Influenza vaccine
PE20090146A1
(en)
*
2007-04-20
2009-03-23
Glaxosmithkline Biolog Sa
IMMUNOGENIC COMPOSITION AGAINST THE INFLUENZA VIRUS
WO2008153236A1
(en)
*
2007-06-15
2008-12-18
Protheon Co., Ltd
An attenuated influenza virus and a live vaccine comprising the same
WO2010144797A2
(en)
2009-06-12
2010-12-16
Vaccine Technologies, Incorporated
Influenza vaccines with enhanced immunogenicity and uses thereof
Family Cites Families (2)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US4552758A
(en)
*
1983-12-20
1985-11-12
St. Jude Children’s Research Hospital
Human use of avian-human reassortants as vaccines for influenza A virus
US4552757A
(en)
*
1983-12-20
1985-11-12
St. Jude Children’s Research Hospital
Use in an animal host and precursors for vaccines utilizing avian-human reassortants to combat influenza A virus
1990
1990-06-27
US
US07/544,823
patent/US5149531A/en
not_active
Expired – Fee Related
1991
1991-06-24
WO
PCT/US1991/004513
patent/WO1992000097A1/en
unknown
1991-06-24
AU
AU81931/91A
patent/AU8193191A/en
not_active
Abandoned
Also Published As
Publication number
Publication date
US5149531A
(en)
1992-09-22
WO1992000097A1
(en)
1992-01-09
Similar Documents
Publication
Publication Date
Title
AU8193191A
(en)
1992-01-23
Method of using cold-adapted live influenza virus vaccine as an antiviral agent against influenza
MA22842A1
(en)
1993-10-01
PROCESS FOR THE PREPARATION OF VACCINE COMPOSITIONS.
DE69826735D1
(en)
2004-11-04
Process for the preparation of 9- (2- (diethylphosphonomethoxy) ethyl) adenine
AU2291895A
(en)
1995-11-10
Inhibitors of influenza virus neuraminidase and methods of making and using the same
CA2291994A1
(en)
1991-10-25
Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
AU1308495A
(en)
1995-08-01
Influenza vaccine
AU1259288A
(en)
1988-11-10
Fluorinated nucleosides: method for their preparation and use as drugs against the human acquired immunodeficiency syndrome (aids)
MA23850A1
(en)
1996-12-31
PROCESS FOR THE PREPARATION OF VACCINATION COMPOSITIONS
MA23918A1
(en)
1996-12-31
PROCESS FOR THE PREPARATION OF VACCINATION COMPOSITIONS
EP0719864A3
(en)
1996-12-04
Recombinant live avian vaccin, using an avian herpes virus as vector
MA23814A1
(en)
1996-10-01
PROCESS FOR THE PREPARATION OF VACCINATION COMPOSITIONS
PL324906A1
(en)
1998-06-22
Vaccines against viral hepatitis of c type
PL311036A1
(en)
1996-01-22
Method of obtaining an anticarcinogenic vaccine
AU8684991A
(en)
1992-05-07
Novel muramyldipeptide derivatives and influenza vaccine comprising the derivatives
AU9128391A
(en)
1992-05-26
Bovine respiratory syncytial virus genes
EP0366238A3
(en)
1990-07-25
Influenza vaccinal polypeptides
AU5168496A
(en)
1996-08-14
Butyryl-tyrosinyl spermine, analogs thereof and methods of preparing and using same
AU5679394A
(en)
1994-06-22
Hepatitis b virus vaccines
BR9708979A
(en)
1999-08-03
Immunogenic complex use of the same vaccine process for the preparation of an immunogenic complex and use of a protein
ZA964094B
(en)
1996-12-03
Compositions and methods for the diagnosis of and vaccination against hepatitis c virus (hcv)
AU3614493A
(en)
1993-09-01
Non-toxic lipid vaccine formulations
AU5474190A
(en)
1990-11-08
Canine corona virus vaccine
AU639746B2
(en)
1993-08-05
Use of benzylphosphonic acid derivatives for the treatment of diseases caused by viruses
AU2775692A
(en)
1994-04-12
Recombinant influenza virus vaccine compositions
CA2087003A1
(en)
1992-03-01
Hrsv vaccine
None